{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-106636","form_type":"8-K","ticker":"LAB","cik":"0001162194","company_name":"STANDARD BIOTOOLS INC.","filed_at":"2025-08-11T23:59:59+00:00","discovered_at":"2026-05-14T18:02:43.463107+00:00","generated_at":"2026-05-17T15:10:58.450782+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Standard BioTools Q2 revenue $21.8M, net loss improves; sells SomaLogic to Illumina for up to $425M","bullets":["Q2 2025 continuing ops revenue $21.8M, down 3% YoY; net loss $17.7M vs $25.4M loss a year ago.","Consumables revenue up 18% YoY to $10.5M; instruments down 26% to $5.2M; services down 8% to $6.1M.","Adjusted EBITDA loss $16.1M vs $17.4M; targeting adjusted EBITDA breakeven in 2026.","Announced sale of SomaLogic to Illumina for up to $425M cash plus royalties; expected close H1 2026.","FY2025 revenue outlook: combined $165-175M; continuing ops $78-83M; cash $239.7M, expects ≥$550M post-close."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-106636","json":"https://secwatch.observer/filing/0000950170-25-106636.json","markdown":"https://secwatch.observer/filing/0000950170-25-106636.md","text":"https://secwatch.observer/filing/0000950170-25-106636.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1162194/000095017025106636/0000950170-25-106636-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1162194/000095017025106636/lab-20250811.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T15:10:58.450782+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}